The global patent landscape of HER2-targeted biologics

Nat Biotechnol. 2023 Jun;41(6):756-764. doi: 10.1038/s41587-023-01814-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products* / therapeutic use
  • Patents as Topic*
  • Receptor, ErbB-2* / antagonists & inhibitors

Substances

  • Biological Products
  • Receptor, ErbB-2